We therefore hypothesized that during the progression of AD, the early dysfunction of BVR-A (1) impairs the activation of the insulin signaling pathway and in parallel (2) fosters CK1-mediated BACE1 recycling at the plasma membrane, where BACE1 cleaves APP, increasing Aβ production. This evidence concerns the gene BLVRA and Alzheimer disease.